journal article·2021-07-07

Logic-Gated Cell-Derived Nanovesicles via DNA-Based Smart Recognition Module

Huidong Huang, Zhenzhen Guo, Chunjuan Zhang, Cheng Cui, Ting Fu, Qiaoling Liu, Weihong Tan

ACS Applied Materials & Interfaces· Volume 13· Issue 26
Publisher page

Abstract

Engineering cell-derived nanovesicles with active-targeting ligands is an important strategy to enhance the targeting efficiency. However, the enhanced binding capability to targeting cells also leads to the binding with nontarget cells that share the same biomarkers. DNA-based logic gate is a kind of molecular system that responds to chemical inputs by generating output signals, and the relationship between the input and the output is based on a certain logic. Thus, the DNA-based logic gate could provide a new approach to improve the delivery efficiency of the nanovesicle. In this work, we developed a DNA logic-gated module that coupled two tumor cell-targeting factors (e.g., low pH and a tumor cell biomarker) in a Boolean manner. Immobilization of this module on the surface of the nanovesicle enables the nanovesicle to sense tumor cell-targeting factors and regard these cues as inputs AND logic gate. With the guide of DNA-based logic gate, gold carbon dots (GCDs) encapsulated within nanovesicles were delivered into target cells, and then the intracellular redox status variation was reflected by fluorescence change of GCDs. Overall, we developed DNA logic-gated nanovesicles that contract different targeting factors into a unique tag for target cells. This facile functionalization strategy can pave the way for constructing smart nanovesicles and would broaden their application in the field of precision medicine and personalized treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, Hunan 410082, China

The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China

Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, China

Funding

National Natural Science Foundation of China · Hunan Provincial Key Area R&D Program · Beijing National Laboratory for Molecular Sciences · Department of Chinese Academy of Sciences Consultation and Evaluation Project

References (38)

Show source-provided references
1. 10.2217/nnm-2016-010210.2217/nnm-2016-0102 ↗
2. 10.1038/nri85510.1038/nri855 ↗
3. 10.1039/c3nr01541f10.1039/c3nr01541f ↗
4. 10.1021/acsnano.8b0258710.1021/acsnano.8b02587 ↗
5. 10.1002/adfm.20160143010.1002/adfm.201601430 ↗
6. 10.1002/adhm.20170038110.1002/adhm.201700381 ↗
7. 10.1038/s41551-019-0405-410.1038/s41551-019-0405-4 ↗
8. 10.1038/ncomms228210.1038/ncomms2282 ↗
9. 10.1002/adfm.20170348210.1002/adfm.201703482 ↗
10. 10.1039/C8SC03224F10.1039/C8SC03224F ↗
11. 10.1038/s41467-020-18626-y10.1038/s41467-020-18626-y ↗
12. 10.1038/nrd397810.1038/nrd3978 ↗
13. 10.1002/advs.20170044910.1002/advs.201700449 ↗
14. 10.1038/nbt.180710.1038/nbt.1807 ↗
15. 10.1021/acsnano.6b0760710.1021/acsnano.6b07607 ↗
16. 10.1039/c3nr03064d10.1039/c3nr03064d ↗
17. 10.1021/acs.nanolett.9b0014510.1021/acs.nanolett.9b00145 ↗
18. 10.1038/s41565-017-0012-z10.1038/s41565-017-0012-z ↗
19. 10.1002/anie.20151014210.1002/anie.201510142 ↗
20. 10.1021/jacs.9b0000710.1021/jacs.9b00007 ↗
21. 10.1002/anie.20200336710.1002/anie.202003367 ↗
22. 10.1002/adma.20170535010.1002/adma.201705350 ↗
23. 10.1021/ja411490310.1021/ja4114903 ↗
24. 10.1016/j.leukres.2012.07.00410.1016/j.leukres.2012.07.004 ↗
25. 10.1158/0008-5472.CAN-17-288010.1158/0008-5472.CAN-17-2880 ↗
26. 10.1021/acsnano.9b0465110.1021/acsnano.9b04651 ↗
27. 10.1021/ar900101s10.1021/ar900101s ↗
28. 10.1002/anie.20200796210.1002/anie.202007962 ↗
29. 10.1007/s00232-020-00154-x10.1007/s00232-020-00154-x ↗
30. 10.1021/jacs.9b0547010.1021/jacs.9b05470 ↗
31. 10.1038/s41598-018-26957-610.1038/s41598-018-26957-6 ↗
32. 10.1039/C8CC04420A10.1039/C8CC04420A ↗
33. 10.1021/acsami.5b1208410.1021/acsami.5b12084 ↗
34. 10.1038/ncomms1608710.1038/ncomms16087 ↗
35. 10.1038/nchem.264810.1038/nchem.2648 ↗
36. Kuppusamy P. · Cancer Res. · 2002 · 62 · 307
37. 10.1186/s12943-016-0526-210.1186/s12943-016-0526-2 ↗
38. 10.34133/2019/652397010.34133/2019/6523970 ↗